To fulfill the promise of genetic medicine by developing transformative therapies for people with devastating CNS diseases Deep experience in rare disease, CNS disorders and genetic medicines LEADERSHIP TEAM William Chou, M.D. Chief Executive Officer Desiree Luthman, D.D.S. SVP Global Regulatory Affairs Alex Fotopoulos Chief Technology Officer Mark Forman, M.D., Ph.D. Chief Medical Officer O A C A D I Simona King Chief Financial Officer Chip Cale General Counsel & Corporate Secretary BOARD OF DIRECTORS Maxi ...